IRIS

Ethylbenzene

CASRN 100-41-4 | DTXSID3020596

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (21 pp, 148 K) Last Updated: 01/31/1987

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Hepatic, Urinary 1 x 10-1 Liver and kidney toxicity NOEL : 9.71 x 101
mg/kg-day
1000 Low

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (21 pp, 148 K) Last Updated: 03/01/1991

System RfC (mg/m3) Basis PoD Composite UF Confidence
Developmental 1 Developmental toxicity NOAEL (HEC): 4.34 x 102
mg/m3
300 Low

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (21 pp, 148 K) Last Updated: 09/17/1988

WOE Characterization Framework for WOE Characterization
D (Not classifiable as to human carcinogenicity) Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986)
Basis:
  • Nonclassifiable due to lack of animal bioassays and human studies.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (21 pp, 148 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (21 pp, 148 K)

Not assessed under the IRIS Program.

Additional EPA toxicity information may be available by visiting the following sites:

Ethylbenzene is being reassessed.

Assessment Manager(s): Andrew Kraft (kraft.andrew@epa.gov), Dahnish Shams (shams.dahnish@epa.gov)

Step Assessment Materials Released to the Public Release Date Public Meeting Date
1 Problem Formulation Materials 09/2017 09/2017
1 Preliminary Assessment Materials 02/2023 N/A
4 Public Comment Draft TBD TBD
4 Peer Review Draft TBD TBD
7 Post Final Assessment TBD

Please note: Any future dates displayed under Release Date are estimates and subject to change.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.

Quick Check